oNKo-innate is a leading innate immune drug discovery and development company located in Melbourne, Australia. With a focus on how the immune system might be better harnessed to treat cancer, we have developed unique full-stack biology and modality platforms capable of discovering, validating and prosecuting new and emerging therapeutic targets.